These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 29288126

  • 1. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR, Rees J, Liu SM, Acharya KR.
    J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
    [Abstract] [Full Text] [Related]

  • 2. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA.
    mBio; 2018 Mar 27; 9(2):. PubMed ID: 29588398
    [Abstract] [Full Text] [Related]

  • 3. Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
    Henkel JS, Jacobson M, Tepp W, Pier C, Johnson EA, Barbieri JT.
    Biochemistry; 2009 Mar 24; 48(11):2522-8. PubMed ID: 19256469
    [Abstract] [Full Text] [Related]

  • 4. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
    Kull S, Schulz KM, Weisemann J, Kirchner S, Schreiber T, Bollenbach A, Dabrowski PW, Nitsche A, Kalb SR, Dorner MB, Barr JR, Rummel A, Dorner BG.
    PLoS One; 2015 Mar 24; 10(2):e0116381. PubMed ID: 25658638
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the functional activity of botulinum neurotoxin subtype B6.
    Kohda T, Nakamura K, Hosomi K, Torii Y, Kozaki S, Mukamoto M.
    Microbiol Immunol; 2017 Nov 24; 61(11):482-489. PubMed ID: 28898517
    [Abstract] [Full Text] [Related]

  • 6. Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells.
    Kohda T, Tsukamoto K, Torii Y, Kozaki S, Mukamoto M.
    Microbiol Immunol; 2020 Jul 24; 64(7):502-511. PubMed ID: 32301520
    [Abstract] [Full Text] [Related]

  • 7. High-resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6.
    Davies JR, Britton A, Liu SM, Acharya KR.
    FEBS Open Bio; 2020 Aug 24; 10(8):1474-1481. PubMed ID: 32654405
    [Abstract] [Full Text] [Related]

  • 8. Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside.
    Gregory KS, Mojanaga OO, Liu SM, Acharya KR.
    Toxins (Basel); 2022 Feb 08; 14(2):. PubMed ID: 35202156
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.
    Smith TJ, Hill KK, Foley BT, Detter JC, Munk AC, Bruce DC, Doggett NA, Smith LA, Marks JD, Xie G, Brettin TS.
    PLoS One; 2007 Dec 05; 2(12):e1271. PubMed ID: 18060065
    [Abstract] [Full Text] [Related]

  • 10. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
    Kroken AR, Blum FC, Zuverink M, Barbieri JT.
    Infect Immun; 2017 Jan 05; 85(1):. PubMed ID: 27795365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Structural Features of Clostridium botulinum Neurotoxin Subtype A2 Cell Binding Domain.
    Gregory KS, Mahadeva TB, Liu SM, Acharya KR.
    Toxins (Basel); 2022 May 19; 14(5):. PubMed ID: 35622602
    [Abstract] [Full Text] [Related]

  • 13. Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3.
    Leka O, Wu Y, Li X, Kammerer RA.
    J Biol Chem; 2021 May 19; 296():100684. PubMed ID: 33891946
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside.
    Gregory KS, Liu SM, Acharya KR.
    FEBS Open Bio; 2020 Mar 19; 10(3):298-305. PubMed ID: 31945264
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
    Wang D, Krilich J, Pellett S, Baudys J, Tepp WH, Barr JR, Johnson EA, Kalb SR.
    Biochim Biophys Acta; 2013 Dec 19; 1834(12):2722-8. PubMed ID: 24096023
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differentiation of Clostridium botulinum serotype A strains by multiple-locus variable-number tandem-repeat analysis.
    Macdonald TE, Helma CH, Ticknor LO, Jackson PJ, Okinaka RT, Smith LA, Smith TJ, Hill KK.
    Appl Environ Microbiol; 2008 Feb 19; 74(3):875-82. PubMed ID: 18083878
    [Abstract] [Full Text] [Related]

  • 19. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
    Shi DY, Lu JS, Mao YY, Liu FJ, Wang R, Du P, Yu S, Yu YZ, Yang ZX.
    Appl Microbiol Biotechnol; 2023 May 19; 107(10):3205-3216. PubMed ID: 37058230
    [Abstract] [Full Text] [Related]

  • 20. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S, Ponmariappan S, Sharma A, Kamboj DV, Jain AK.
    Protein Pept Lett; 2017 May 19; 24(6):495-502. PubMed ID: 28260503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.